Inactive Instrument
Abliva AB Stock
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 10/01/2014 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/02/2023 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 06/11/2017 | |
| Director/Board Member | 66 | 27/04/2017 | |
David Bejker
BRD | Director/Board Member | 51 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/03/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 07/03/25 | Sell | Founder | 574,978 | 0.0357% | ||
| 12/02/25 | Sell | Chief Technology Officer | 3,104,000 | 0.1926% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 76M | |
| +4.21% | +25.62% | +77.96% | +111.62% | 68.12B | |
| +0.50% | +2.95% | +34.94% | +69.77% | 55.18B | |
| +2.78% | +36.66% | +23.00% | +526.16% | 28.63B | |
| +0.57% | +19.05% | +57.08% | +5.18% | 23.99B | |
| -0.93% | +2.45% | -16.89% | -12.86% | 23.53B | |
| -0.35% | +7.18% | +44.14% | -22.28% | 18.45B | |
| -2.04% | +9.24% | +31.14% | +650.71% | 16.44B | |
| +7.26% | +25.47% | +221.03% | +383.67% | 15.83B | |
| -2.05% | -0.13% | +40.40% | +156.84% | 13.4B | |
| Average | +1.02% | +10.15% | +56.98% | +207.65% | 29.28B | |
| Weighted average by Cap. | +1.64% | +11.47% | +54.01% | +169.97% |
Employees
6
